000 01208 a2200337 4500
005 20250516102607.0
264 0 _c20121002
008 201210s 0 0 fre d
022 _a0767-0974
024 7 _a10.1051/medsci/2012286008
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNicoletti, Antonino
245 0 0 _a[Should we block interleukin-1 in atherothrombosis?].
_h[electronic resource]
260 _bMedecine sciences : M/S
_c
300 _a580-2 p.
_bdigital
500 _aPublication Type: News
650 0 4 _aAntibodies
_xtherapeutic use
650 0 4 _aEmbolism, Cholesterol
_xcomplications
650 0 4 _aHumans
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aInterleukin-1
_xantagonists & inhibitors
650 0 4 _aModels, Biological
650 0 4 _aMolecular Targeted Therapy
_xstatistics & numerical data
650 0 4 _aPlaque, Atherosclerotic
_xcomplications
650 0 4 _aThrombosis
_xcomplications
700 1 _aCaligiuri, Giuseppina
700 1 _aHo-Tin-NoƩ, Benoit
700 1 _aMichel, Jean-Baptiste
773 0 _tMedecine sciences : M/S
_gvol. 28
_gno. 6-7
_gp. 580-2
856 4 0 _uhttps://doi.org/10.1051/medsci/2012286008
_zAvailable from publisher's website
999 _c21951834
_d21951834